|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
173,744,000 |
Market
Cap: |
1.07(B) |
Last
Volume: |
148,509 |
Avg
Vol: |
0 |
52
Week Range: |
$5.58 - $15.45 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 8.3 |
Insider 3/6 Months : 8.9 |
|
Guru Rank Number : 607 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focusing on developing the treatment of GI diseases. LINZESS® (linaclotide), Co.'s commercial product, is a product in a class of GI medicines called guanylate cyclase type C agonists and is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is available to adult men and women suffering from IBS-C or CIC in the U.S. and Mexico and to adult men and women suffering from IBS-C in Japan and China. Co. has partnerships with pharmaceutical companies to support the development and commercialization of linaclotide.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
17,604 |
53,676 |
53,676 |
Total Buy Value |
$0 |
$160,420 |
$460,539 |
$460,539 |
Total People Bought |
0 |
2 |
2 |
2 |
Total Buy Transactions |
0 |
2 |
3 |
3 |
Total Shares Sold |
226,641 |
507,557 |
529,791 |
1,205,966 |
Total Sell Value |
$1,459,885 |
$5,741,044 |
$5,974,538 |
$13,645,593 |
Total People Sold |
6 |
7 |
8 |
11 |
Total Sell Transactions |
7 |
12 |
16 |
50 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Roberts Bryan E |
Director |
|
2015-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
64 |
15,085 |
|
- |
|
Roberts Bryan E |
Director |
|
2015-03-03 |
4 |
A |
$0.00 |
$0 |
I/I |
148 |
253 |
|
- |
|
Roberts Bryan E |
Director |
|
2015-03-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,936,202) |
0 |
|
- |
|
Hecht Peter M |
Chief Executive Officer |
|
2015-03-03 |
4 |
S |
$15.71 |
$97,402 |
D/D |
(6,200) |
4,141,417 |
|
- |
|
Hecht Peter M |
Chief Executive Officer |
|
2015-03-03 |
4 |
OE |
$1.56 |
$9,672 |
D/D |
6,200 |
4,147,617 |
|
- |
|
Hecht Peter M |
Chief Executive Officer |
|
2015-03-02 |
4 |
S |
$16.00 |
$222,528 |
D/D |
(13,908) |
4,141,417 |
|
- |
|
Hecht Peter M |
Chief Executive Officer |
|
2015-03-02 |
4 |
OE |
$1.56 |
$21,696 |
D/D |
13,908 |
4,155,325 |
|
- |
|
Hecht Peter M |
Chief Executive Officer |
|
2015-02-27 |
4 |
S |
$15.34 |
$679,432 |
D/D |
(43,334) |
4,141,417 |
|
- |
|
Hecht Peter M |
Chief Executive Officer |
|
2015-02-27 |
4 |
OE |
$0.60 |
$126,000 |
D/D |
210,000 |
4,184,751 |
|
- |
|
Cook Joseph C Jr |
Director |
|
2015-02-20 |
4 |
AS |
$15.63 |
$40,638 |
D/D |
(2,600) |
46,575 |
|
- |
|
Cook Joseph C Jr |
Director |
|
2015-02-19 |
4 |
AS |
$15.60 |
$513,240 |
D/D |
(32,900) |
49,175 |
|
- |
|
Currie Mark G |
Chief Scientific Officer |
|
2015-02-19 |
4 |
AS |
$15.67 |
$391,750 |
D/D |
(25,000) |
310,000 |
|
- |
|
Currie Mark G |
Chief Scientific Officer |
|
2015-02-19 |
4 |
OE |
$0.60 |
$15,000 |
D/D |
25,000 |
335,000 |
|
- |
|
Conrades George N |
Director |
|
2015-02-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(254,152) |
0 |
|
- |
|
Cook Joseph C Jr |
Director |
|
2014-12-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,800 |
82,075 |
|
- |
|
Higgins Michael J |
Chief Operating Officer |
|
2014-12-23 |
4 |
OE |
$1.56 |
$45,399 |
D/D |
29,102 |
329,102 |
|
- |
|
Cook Joseph C Jr |
Director |
|
2014-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,200 |
306,163 |
|
- |
|
Cook Joseph C Jr |
Director |
|
2014-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
32,400 |
325,363 |
|
- |
|
Cook Joseph C Jr |
Director |
|
2014-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,200 |
89,875 |
|
- |
|
Higgins Michael J |
Chief Operating Officer |
|
2014-12-16 |
4 |
S |
$14.01 |
$223,978 |
D/D |
(15,987) |
300,000 |
|
- |
|
Higgins Michael J |
Chief Operating Officer |
|
2014-12-16 |
4 |
OE |
$2.94 |
$47,002 |
D/D |
15,987 |
315,987 |
|
- |
|
Ebersman David A |
Director |
|
2014-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
182 |
29,549 |
|
- |
|
Walsh Christopher T Phd |
Director |
|
2014-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
182 |
29,549 |
|
- |
|
Roberts Bryan E |
Director |
|
2014-12-15 |
4 |
A |
$13.70 |
$2,493 |
D/D |
182 |
15,401 |
|
- |
|
Roberts Bryan E |
Director |
|
2014-12-15 |
4 |
S |
$15.06 |
$18,072 |
I/I |
(1,200) |
16,498 |
|
- |
|
589 Records found
|
|
Page 22 of 24 |
|
|